ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
Dow Jones
38,239.66
0.40%
US Dollar vs MXN
17.1601
0.00%
Brent Oil
88.165
0.00%
Bitcoin
63,312.37
-0.67%
Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Sana Biotechnology Inc (SANA)

  7. Sana Biotechnology Inc (SANA) Noticias

SANA Sana Biotechnology Inc

8.72
0.22 (2.59%)
26 Abr 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Sana Biotechnology Inc SANA NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.22 2.59% 8.72 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
8.57 8.46 8.88 8.72 8.50
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
08/3/202415:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202415:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202415:12EDGAR2Form 8-K - Current report
29/2/202415:05GLOBESana Biotechnology Reports Fourth Quarter and Full Year 2023..
28/2/202415:05GLOBESana Biotechnology to Present at the Cowen 44th Annual..
14/2/202415:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
13/2/202415:05GLOBESana Biotechnology Announces Publication of Preclinical..
12/2/202415:05GLOBESana Biotechnology Announces Closing of Upsized Public..
08/2/202416:20EDGAR2Form 8-K - Current report
08/2/202415:49EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
08/2/202400:22GLOBESana Biotechnology Announces Pricing of Upsized Public..
07/2/202420:59EDGAR2Form FWP - Filing under Securities Act Rules 163/433 of free..
07/2/202416:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
07/2/202415:12EDGAR2Form 8-K - Current report
07/2/202415:01GLOBESana Biotechnology Announces Proposed Public Offering of..
09/1/202408:00EDGAR2Form 8-K - Current report
05/1/202408:00GLOBESana Biotechnology Announces FDA Clearance of..
03/1/202415:05GLOBESana Biotechnology to Present at the 42nd Annual J.P. Morgan..
18/12/202315:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/12/202315:34EDGAR2Form 144 - Report of proposed sale of securities
11/12/202315:01EDGAR2Form 8-K - Current report
11/12/202308:00GLOBESana Biotechnology Highlights Preclinical Data Supporting..
01/12/202315:05GLOBESana Biotechnology Publishes Early Clinical Data Showing..
27/11/202318:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202308:00GLOBESana Biotechnology to Present at November and December 2023..
21/11/202305:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
17/11/202308:00GLOBEUppsala University Hospital and Sana Biotechnology Announce..
09/11/202315:05GLOBESana Biotechnology Announces FDA Clearance of..
08/11/202315:24EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202315:14EDGAR2Form 8-K - Current report
08/11/202315:05GLOBESana Biotechnology Reports Third Quarter 2023 Financial..
03/11/202315:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/11/202315:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/11/202308:05GLOBESana Biotechnology Announces Five Presentations at the 65th..
01/11/202309:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
10/10/202315:21EDGAR2Form 8-K - Current report
10/10/202315:15GLOBESana Biotechnology Announces Increased Focus on..
13/9/202305:04EDGAR2Form 8-K - Current report
11/9/202305:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
30/8/202315:05GLOBESana Biotechnology to Present at September 2023 Investor..
29/8/202308:00PRNUSInvaio achieves first registration for citrus greening..
21/8/202315:05EDGAR2Form 8-K - Current report
03/8/202315:23EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202315:14EDGAR2Form 8-K - Current report
03/8/202315:05GLOBESana Biotechnology Reports Second Quarter 2023 Financial..
16/6/202308:00GLOBESana Biotechnology Highlights Preclinical Data from..
31/5/202315:05GLOBESana Biotechnology to Present at June 2023 Investor..
16/5/202305:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..
08/5/202315:35GLOBESana Biotechnology Announces Preclinical Data Published in..
08/5/202315:05GLOBESana Biotechnology Reports First Quarter 2023 Financial..

Su Consulta Reciente

NASDAQ
SANA
Sana Biotechnology
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados